| 000 -LEADER |
|---|
| fixed length control field |
02076cam a2200325 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20191009160338.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100903s2011 gw a b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783527317905 (hbk. : alk. paper) |
|
|---|
| International Standard Book Number |
3527317902 (hbk. : alk. paper) |
| 041 ## - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM666.E548 |
| Item number |
P76 2011 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.798 |
| Edition number |
22 |
| Item number |
P76 |
| 245 00 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Protein kinases as drug targets / |
| Statement of responsibility, etc |
edited by Bert Klebl, Gerhard Muller, and Michael Hamacher. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Weinheim : |
| Name of publisher, distributor, etc |
Wiley-VCH ; |
| Date of publication, distribution, etc |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxi, 373 p. : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
25 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| 9 (RLIN) |
4233 |
| Title |
Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation |
v. 49. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
In vitro characterization of small-molecule kinase inhibitors -- Screening for kinase inhibitors: from biochemical to cellular assays -- Dissecting phosphorylation networks: the use of analogue-sensitive kinases and more specific kinase inhibitors as tools -- Rational drug design of kinase inhibitors for signal transduction therapy -- Kinase inhibitors in signal transduction therapy -- Design principles of deep pocket-targeting protein kinase inhibitors -- From discovery to clinic: aurora kinase inhibitors as novel treatments for cancer -- Discovery and design of protein kinase inhibitors: targeting the cell cycle in oncology -- Medicinal chemistry approaches for the inhibition of the p38 MAPK pathway -- Cellular protein kinases as antiviral targets -- Prospects for TB therapeutics targeting mycobacterium tuberculosis phosphosignaling networks. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Protein Kinase Inhibitors |
| General subdivision |
therapeutic use. |
| 9 (RLIN) |
4227 |
|
|---|
| Topical term or geographic name as entry element |
Drug delivery systems. |
| 9 (RLIN) |
3648 |
|
|---|
| Topical term or geographic name as entry element |
Drug Discovery. |
| 9 (RLIN) |
4196 |
|
|---|
| Topical term or geographic name as entry element |
Protein kinases |
| General subdivision |
Inhibitors. |
| 9 (RLIN) |
4228 |
|
|---|
| Topical term or geographic name as entry element |
Antineoplastic agents |
| General subdivision |
Development. |
| 9 (RLIN) |
4229 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Klebl, Bert. |
| 9 (RLIN) |
4230 |
| Relator term |
editor |
|
|---|
| Personal name |
Hamacher, Michael. |
| 9 (RLIN) |
4232 |
| Relator term |
editor |
|
|---|
| 9 (RLIN) |
4231 |
| Personal name |
Muller, Gerhard, |
| Dates associated with a name |
1963- |
| Relator term |
editor |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation |
v. 49. |
| 9 (RLIN) |
4233 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
